🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Muscular Dystrophies

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression NCT06079567NA9 sites📍 Leuven📍 Nice📍 Marseille Centre Hospitalier Universitaire de Nice · Tests: Validation of new COMs for FSHD2 patients Clinical Trial Readiness for the Dystroglycanopathies NCT00313677n/a1 site📍 Iowa City Katherine Mathews A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. NCT07058662Phase 1, Phase 21 site📍 Beijing Belief BioMed (Beijing) Co., Ltd · Tests: Single dose intravenous of BBM-D101 Muscle Health Measurements Using Electrical Impedance Myography NCT07502989n/a1 site📍 Boston Beth Israel Deaconess Medical Center · Tests: Electrical Impedance Myography Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study NCT03373968Phase 2, Phase 339 sites📍 Sacramento📍 San Diego📍 Hartford Italfarmaco · Tests: Givinostat The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry NCT04001582n/a1 site📍 Newcastle upon Tyne Newcastle University · Tests: Patient Registry A Remote Study Using Technology to Assess Outcomes in DMD NCT07423026n/a1 site📍 Oxford University of Oxford Biomarker Development for Muscular Dystrophies NCT05019625n/a5 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) NCT07220603Phase 23 sites📍 Calgary📍 Ottawa📍 Saguenay PepGen Inc · Tests: PGN-EDODM1 Swiss Registry for Neuromuscular Disorders NCT05102916n/a19 sites📍 Aarau📍 Bellinzona📍 Lugano University of Bern Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy NCT06075693n/a1 site📍 Boston Massachusetts General Hospital Natural History Study of Children With LAMA2-related Dystrophies NCT06354790n/a4 sites📍 Garches📍 Lyon📍 Montpellier Institut de Myologie, France · Tests: Motor evaluations, Cognitive assessment, Pulmonary function test, Cardiac evaluation, Quality of life Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy NCT07630389n/a1 site📍 Rochester University of Rochester Study of Inherited Neurological Disorders NCT00004568n/a2 sites📍 Bethesda📍 Bamako National Institute of Neurological Disorders and Stroke (NI… Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies NCT07138963n/a1 site📍 Cairo Ain Shams University · Tests: Genetic Testing and Muscle Biopsy A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy NCT07673809Phase 1, Phase 26 sites📍 Minsk📍 Moscow📍 Moscow AO GENERIUM · Tests: GNR-097, Placebo followed by GNR-097 Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) NCT07521930NA1 site📍 Baltimore Johns Hopkins University · Tests: INTENT Neural Interface System Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) NCT07086521Phase 11 site📍 Palo Alto Restem, LLC. · Tests: ULSC, Placebo Urinary Titin Biomarker in DMD NCT07332013NA1 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: Descending stair walk Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation NCT06227182n/a1 site📍 Nijmegen Radboud University Medical Center · Tests: Muscle ultrasound with surface electromyography and dynamometry, MRI scan Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy NCT07362875n/a1 site📍 Winston-Salem Wake Forest University Health Sciences DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies NCT07515235n/a1 site📍 Thessaloniki Aristotle University Of Thessaloniki Rare Disease Registry Database for Movement Disorders in Southern Anhui Province NCT07838883n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy NCT07172971Phase 11 site📍 Nashville Vanderbilt University Medical Center · Tests: SGLT-2 inhibitor, SGLT2 inhibitor Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry NCT00082108n/a1 site📍 Rochester University of Rochester Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients NCT07766980Phase 21 site📍 Gainesville University of Florida · Tests: VM100 Nutritional Supplement A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia NCT06185673Phase 1, Phase 21 site📍 New York Benitec Biopharma, Inc. · Tests: BB-301: Dose escalation phase 1b cohort 1, BB-301: Dose escalation phase 1b cohort 2, BB-301: Dose escalation phase 1b … A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) NCT06138639Phase 1, Phase 215 sites📍 Little Rock📍 Los Angeles📍 Sacramento Solid Biosciences Inc. · Tests: SGT-003 Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds) NCT06847282n/a7 sites📍 Palo Alto📍 Iowa City📍 Kansas City University of Kansas Medical Center
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy